Replies to post #4646 on Arch Therapeutics Inc (ARTH)

[scottsmith]

Wow great story!!

[512]

Thanks for sharing:)

[Regis999]

You always have great stories...BBQ's etc. I lived for many years in Ridgewood /NYC. great area.

I wonder when the doctors will come flooding into stock.

Did you attend Dr. Norchi's NYC presentation? Have you met him?

Since JNJ has 60% of the hemostasis market it is extremely important that they address Arch.

Arch ties to JNJ


1) Dr. Arthur L. J. Rosenthal, Ph.D., also known as Art serves as Advisor of Arch Therapeutics, Inc. He served as a Vice President of Research and Development at Johnson & Johnson Medical, Inc., from April 1990 to January 1994, and was in charge of worldwide research, development, regulatory, and clinical affairs for the JJMI Division—Google Arthur L. J. Rosenthal Ph.D. to see his impressive background.

2) retired former COO of Arch William Cotter was one of key officers of Closure Medical Corporation which was sold to JNJ in 2005.See Arch press release Arch Therapeutics Appoints Senior Management Team Members CAMBRIDGE, MA -- (Marketwired) -- 07/08/13

Johnson & Johnson and CLOSURE Medical Corporation Announce Acquisition Agreement

Acquisition to Strengthen Presence in Topical Adhesives and Surgical Sealants

NEW BRUNSWICK, N.J. and RALEIGH, N.C., March 4, 2005 $370 million

[derkampfer]

So ... what kind of "smile" was it? A smile like "we know that company and we like what we see?" A smile like "we know that company and we're in talks with them about a partnership?" Or a smile like "we know that company and those guys think they have a great product but they just don't know what the heck they're doing (ARTH)?"

What's your take? Just curious.

[ahab333]

Justfacts, that is very interesting. The smile/no comment is very telling in itself. Thanks for posting that. Who knows? Only the nose knows - GLTU

HCIT